title: Rituximab for the Treatment of Isolated Refractory Desquamative Gingivitis Due to Mucous Membrane Pemphigoid.
authors.affiliation: Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
authors.forename: Stefanie
authors.initials: S
authors.lastname: Haefliger
authors.affiliation: University Institute of Clinical Chemistry and Center of Laboratory Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
authors.forename: Michael P
authors.initials: MP
authors.lastname: Horn
authors.affiliation: Department of Oral Surgery and Stomatology, School of Dental Medicine, University of Bern, Bern, Switzerland.
authors.forename: Valerie G A
authors.initials: VG
authors.lastname: Suter
authors.affiliation: Department of Oral Surgery and Stomatology, School of Dental Medicine, University of Bern, Bern, Switzerland.
authors.forename: Michael M
authors.initials: MM
authors.lastname: Bornstein
authors.affiliation: Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
authors.forename: Luca
authors.initials: L
authors.lastname: Borradori
mesh_terms: D000368:Aged; D003937:Diagnosis, Differential; D004305:Dose-Response Relationship, Drug; D005260:Female; D005891:Gingivitis / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D009092:Mucous Membrane / Q000473:pathology; D010390:Pemphigoid, Benign Mucous Membrane / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D012074:Remission Induction; D000069283:Rituximab / Q000008:administration & dosage*
chemical_list: D007155:Immunologic Factors; D000069283:Rituximab